Top Wall Street analysts pick these stocks for solid returns

Sunday, 21 January 2024 Sunday, 21 January 2024

Worries persist over prolonged elevated interest rates despite stocks reaching new highs.

[{"selector":"#anim-ea1bd2c9-10d4-4577-9ecb-78566e25d32d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1e342890-cee8-4472-9851-9dfe69eaccd6","keyframes":{"transform":["translate3d(0px, -882.96314%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Analysts remain bullish on stocks with attractive long-term growth prospects.

[{"selector":"#anim-1c863700-6b44-4bd5-bc58-2d1ec6d4d43f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8f4f0ff6-e67e-4a70-9183-278684e4582c","keyframes":{"transform":["translate3d(0px, -1302.44518%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

TipRanks lists three stocks favored by top analysts: Amazon, DoorDash, and Nvidia.

[{"selector":"#anim-beaf2798-e2eb-4ed6-9f03-faaaf0ada6a1","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7b8791af-0029-4e9b-bc42-cb12f4e1e155","keyframes":{"transform":["translate3d(0px, -880.29643%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-d6f1ad5f-2fc8-4b5d-a154-400890f97194","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-4bcde988-e0bf-48a8-9d83-76e0cc8f17c9","keyframes":{"transform":["translate3d(0px, -793.20237%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] RBC Capital analyst Brad Erickson reaffirms a buy rating on Amazon (AMZN) with a $180 price target, expecting growth in Amazon Web Services and robust advertising business.

[{"selector":"#anim-f96d5ccc-b59f-4ba9-9ca3-f38296fc6799","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-380aa0fe-f4b8-4aad-9298-2749a03c1933","keyframes":{"transform":["translate3d(0px, -785.14199%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] DoorDash (DASH) receives a buy rating and $120 price target from BMO Capital analyst Brian Pitz, citing strong execution and significant market opportunities.

DoorDash's total addressable market estimated at $2.2 trillion in the U.S. and $2.5 trillion in Europe.

[{"selector":"#anim-7e7566cd-3c24-4f5f-9912-67118e351c10","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a59ded96-350e-434c-9390-2f62de524f48","keyframes":{"transform":["translate3d(0px, -892.29642%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Nvidia (NVDA) earns a buy rating from JPMorgan analyst Harlan Sur, with a $650 price target, driven by the health-care vertical's impressive revenue growth.

[{"selector":"#anim-82e4646a-ff1d-4c73-b975-67f08b01f068","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-908b9a68-7c6d-46ce-84bf-f3cdbc95aca3","keyframes":{"transform":["translate3d(0px, -557.7777%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-dca1b31d-2439-455c-9b63-1fd1a95d42ba","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-65d85a19-cf95-47e8-b960-90b5412d5208","keyframes":{"transform":["translate3d(0px, -715.85653%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Nvidia's health-care business exceeds $1 billion in revenue in FY24, fueled by AI in drug discovery, genomics, diagnostics, and robotics.

Nvidia's generative AI platform for drug discovery, BioNeMo, advances into the beta phase.

[{"selector":"#anim-0cc5e677-5e43-4e37-a046-ce88bff14ae5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3484c730-de82-4015-be6a-46b05b8d80e0","keyframes":{"transform":["translate3d(0px, -886.96308%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-bd5de779-3ffb-4c04-a87a-2c89e1556247","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0c29ce70-b9dd-4ad7-9b5a-421eca3ae577","keyframes":{"transform":["translate3d(0px, -794.37882%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Analysts emphasize the competitive positioning of Nvidia in health care, citing partnerships with Amgen and Recursion Pharmaceuticals.